Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationMultiple MyelomaHematopoietic Stem Cell MobilizationMelphalanTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorCombined Modality TherapyLeukapheresisAntigens, CD34Hematologic NeoplasmsBlood Component RemovalStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideTreatment OutcomeMyeloablative AgonistsBusulfanGraft vs Host DiseaseLymphoma, Non-HodgkinRemission InductionBone Marrow TransplantationGraft SurvivalAntineoplastic Agents, AlkylatingHematopoietic Stem CellsEtoposideRecurrenceThiotepaSalvage TherapyVincristineCarmustineCytophagocytosisDisease-Free SurvivalIfosfamideAmyloidosisBoronic AcidsPyrazinesSurvival RateThalidomideRetrospective StudiesStem CellsDexamethasoneCytarabineHematopoiesisHodgkin DiseaseCord Blood Stem Cell TransplantationPrednisoneTransplantation ChimeraSurvival AnalysisDoxorubicinNeoplasmsTissue DonorsTime FactorsWhole-Body IrradiationInfectionLymphoma, T-CellAntineoplastic AgentsPOEMS SyndromePlatelet CountHistocompatibilityBone MarrowHistocompatibility TestingFollow-Up StudiesCarboplatinImmunosuppressive AgentsLeukemia, Myeloid, AcuteBone Marrow PurgingTransplantation, IsogeneicPlasma CellsRecombinant ProteinsVidarabineBlood Cell CountLeukemiaLymphomaAntibodies, MonoclonalImmunophenotypingPrognosisProspective StudiesFatal OutcomeBlood CellsCytomegalovirus InfectionsGraft vs Leukemia EffectFeasibility StudiesMyeloma ProteinsFlow CytometryParaproteinemiasMyelodysplastic SyndromesAnemia, AplasticBlood Transfusion, AutologousLymphocyte DepletionT-LymphocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow CellsLiver TransplantationLeukocytes, MononuclearHematologic DiseasesOpportunistic InfectionsHistiocytosis, Non-Langerhans-Cell